Biofrontera Inc. Proceeds from Issuance of Private Placement
Biofrontera Inc. (BFRI) reported Proceeds from Issuance of Private Placement of $7.30 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-05-15
- Biofrontera Inc. proceeds from issuance of private placement for the quarter ending 2024-03-31 was $7.30M.
- Biofrontera Inc. proceeds from issuance of private placement for the quarter ending 2022-12-31 was $0.00.
- Biofrontera Inc. proceeds from issuance of private placement for the quarter ending 2022-09-30 was $0.00.
- Biofrontera Inc. proceeds from issuance of private placement for fiscal 2023 was $4.10M.
| Period end | Proceeds from Issuance of Private Placement 0 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $7.30M 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | $4.10M 10-K · filed 2024-03-15 | ||||
| 2022-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $0.00 derived: sum of 2 quarters · filed 2023-10-03 | $9.39M 8-K · filed 2023-10-03 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $9.39M 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $9.39M 10-Q · filed 2022-08-12 | ||||
| 2022-05-16 | $9.40M 10-Q · filed 2022-08-12 | ||||
| 2021-12-31 | $14.99M 8-K · filed 2023-10-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |